| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/24/2008 | US20080020003 Methods for the delivery of a beta2 agonist to induce bronchodilation and formulations for use in the same |
| 01/24/2008 | US20080020000 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 01/24/2008 | US20080019989 Immunity Adjuvant Containing a Complexed Metal Cation and Vaccine Containing Same |
| 01/24/2008 | US20080019927 Compositions and methods for dermally treating neuropathy with minoxidil |
| 01/24/2008 | US20080019926 Lung Surfactant Supplements |
| 01/24/2008 | US20080019925 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 01/24/2008 | US20080019924 optically variable or taggent non-toxic flakes (Zn, ZnO, TiO2, MgO, SiO2 ) used for identification, anticounterfeit protection of pharmaceutical articles (pills, tablets and capsules), having core of a biologically active and/or a biologically inert material; symbol or shapes dispersed with in article |
| 01/24/2008 | US20080019918 Medicinal Preparation |
| 01/24/2008 | US20080019917 Compositions Comprising Cells and Magnetic Materials for Targeted Delivery |
| 01/24/2008 | US20080019904 System For Manufacturing Micro-Sheres |
| 01/24/2008 | US20080017201 Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
| 01/24/2008 | US20080017191 Metered dose inhaler |
| 01/24/2008 | DE102006034009A1 Intraocular application of medicament for glaucoma therapy comprises applying a high concentration of thalidomide on desired place of eye to avoid larger extent of systemic side-effect through intraocular application |
| 01/24/2008 | DE102006033723A1 Formulierungen von Multikompartimenten-Granulaten für Wirkstoffe Formulations of Multikompartimenten granules for drugs |
| 01/24/2008 | DE102006032083A1 Producing microcapsules comprises feeding a first oil and a water phase into emulsification chamber, introducing a material forming second oil phase and emulsifying the first oil and water emulsion in the material using ultrasound waves |
| 01/24/2008 | DE10121982B4 Nanopartikel aus Protein mit gekoppeltem Apolipoprotein E zur Überwindung der Blut-Hirn-Schranke und Verfahren zu ihrer Herstellung Nanoparticles of protein with coupled apolipoprotein E to cross the blood-brain barrier and method for their preparation |
| 01/24/2008 | CA2671200A1 Hydrophilic abuse deterrent delivery system |
| 01/24/2008 | CA2671197A1 Hydrophobic abuse deterrent delivery system |
| 01/24/2008 | CA2660894A1 Film-delivering rinse |
| 01/24/2008 | CA2659662A1 Concentrated methotrexate solutions |
| 01/24/2008 | CA2658571A1 Methods and compositions for the treatment and prevention of infections |
| 01/24/2008 | CA2658395A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/24/2008 | CA2658082A1 Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same |
| 01/24/2008 | CA2657913A1 Controlled release formulations and associated methods |
| 01/24/2008 | CA2657769A1 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 01/24/2008 | CA2657380A1 Devices, systems and methods for ophthalmic drug delivery |
| 01/24/2008 | CA2657346A1 Formulations for benzimidazolyl pyridyl ethers |
| 01/24/2008 | CA2655885A1 Products containing smart foam and method of making |
| 01/24/2008 | CA2618655A1 Compositions and methods for making and using nanoemulsions |
| 01/23/2008 | EP1880762A2 Method of preparing micro- and nanometric particles with labile products |
| 01/23/2008 | EP1880744A1 Bisphosphonic acids for the treatment and prevention of osteoporosis |
| 01/23/2008 | EP1880738A1 Medical composition for promotion of skin regeneration |
| 01/23/2008 | EP1880736A1 Releasable linkage and composition containing same |
| 01/23/2008 | EP1880732A1 Parathyroid hormone formulation |
| 01/23/2008 | EP1880727A2 Topical vaginal pharmaceutical compositions |
| 01/23/2008 | EP1880725A1 Liquid formulation comprising clozapine, quetiapine, a salt of quetiapine and/or olanzapine for oral administration |
| 01/23/2008 | EP1880724A1 Liquid formulation comprising clozapine, quetiapine, a salt of quetiapine and/or olanzapine for oral administration |
| 01/23/2008 | EP1880722A1 Pharmaceutical compositions of ciprofloxacin |
| 01/23/2008 | EP1880718A1 Pharmaceutical preparation for oral administration with controlled drug release in the small intestine colon and process of prepartion thereof |
| 01/23/2008 | EP1880717A2 Systems, Methods and apparatuses for manufacturing dosage forms |
| 01/23/2008 | EP1880716A1 Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient |
| 01/23/2008 | EP1880715A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 01/23/2008 | EP1880714A1 Amorphous Aripiprazole and Process for the Preparation thereof |
| 01/23/2008 | EP1880213A2 Silver/water, silver gels and silver-based compositions; and methods for making and using the same |
| 01/23/2008 | EP1879874A2 Process for preparing quetiapine and quetiapine fumarate |
| 01/23/2008 | EP1879620A2 Medicaments and methods combining an anticholinergic, a corticosteroid, and a long acting beta agonist |
| 01/23/2008 | EP1879603A1 Ejection liquid, ejection method, method for forming liquid droplets, liquid ejection cartridge and ejection apparatus |
| 01/23/2008 | EP1879600A2 Nanotubes as mitochondrial uncouplers |
| 01/23/2008 | EP1879595A2 Compositions and methods for treating hyperproliferative epidermal diseases |
| 01/23/2008 | EP1879589A2 Treatment and control of severe infections including cystic fibrosis |
| 01/23/2008 | EP1879583A2 Quinine formulations |
| 01/23/2008 | EP1879579A1 Inhalation device containing plural doses of a pharmaceutical composition |
| 01/23/2008 | EP1879566A1 Compositions and methods for inhibiting gastric acid secretion |
| 01/23/2008 | EP1879565A2 Topical pharmaceutical formulation containing nimesulide |
| 01/23/2008 | EP1879560A2 Solid transdermal therapeutic system comprising uv absorber |
| 01/23/2008 | EP1879559A2 Oral medicament based on a proton pump inhibitors |
| 01/23/2008 | EP1879558A1 Pharmaceutical composition comprising gas-filled microcapsules for ultrasound mediated delivery |
| 01/23/2008 | EP1879557A1 Morphine sulfate formulations |
| 01/23/2008 | EP1879556A2 Timed, pulsatile release systems |
| 01/23/2008 | EP1879555A2 Dosage form with improved release of cefuroximaxetil |
| 01/23/2008 | EP1879554A2 Compositions and methods using microspheres and non-ionic contrast agents |
| 01/23/2008 | EP1879553A2 Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates |
| 01/23/2008 | EP1879552A2 Drug delivery compositions and related methods |
| 01/23/2008 | EP1879522A2 Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
| 01/23/2008 | EP1879499A2 Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses |
| 01/23/2008 | EP1879456A2 Pharmaceutical compositions with synchronized solubilizer release |
| 01/23/2008 | EP1879449A2 Compositions and methods for skin care |
| 01/23/2008 | EP1545619B1 Solution for ungual application |
| 01/23/2008 | EP1478428A4 Device and method for delivering or withdrawing a substance through the skin |
| 01/23/2008 | EP1311261B1 Medicaments for chemotherapeutic treatment of disease |
| 01/23/2008 | EP1220925B1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/23/2008 | EP1216032B1 Oral controlled release formulations |
| 01/23/2008 | EP1188057B1 Incorporation and applications of biomolecular interactions within a carrier |
| 01/23/2008 | EP1137406B2 Transdermal patch for delivering volatile liquid drugs |
| 01/23/2008 | EP0962226B1 External preparations containing watercress extract |
| 01/23/2008 | CN201008702Y Traditional chinese medicine plaster applying onto umbilicus |
| 01/23/2008 | CN201008658Y Flexible medicament sustained release oral cavity film |
| 01/23/2008 | CN101111539A Spray dried compositions |
| 01/23/2008 | CN101111307A Process for producing coated fine particle |
| 01/23/2008 | CN101111306A Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 01/23/2008 | CN101111269A Composition for inhibiting expression of target gene |
| 01/23/2008 | CN101111258A Emulsified composition for dilution and cancer vaccine composition |
| 01/23/2008 | CN101111253A Therapeutic agent for eye disease |
| 01/23/2008 | CN101111251A Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 01/23/2008 | CN101111245A Extended release formulation of levetiracetam |
| 01/23/2008 | CN101111242A Tablets containing ornithine hydrochloride |
| 01/23/2008 | CN101111233A Stable oral benzimidazole compositions and process of preparation thereof |
| 01/23/2008 | CN101111232A Method for the production of a tamper-proof form of administration |
| 01/23/2008 | CN101111231A Multiparticulate pharmaceutical form comprising pellets with a matrix which influences the delivery of a modulatory substance |
| 01/23/2008 | CN101111230A Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release |
| 01/23/2008 | CN101111229A Formulations of substituted benzoxazoles |
| 01/23/2008 | CN101111228A Formulations of substituted benzoxazoles |
| 01/23/2008 | CN101111227A Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 01/23/2008 | CN101111226A Medical product for inhalation containing glucagon-like peptide-1 (glp-1) |
| 01/23/2008 | CN101111225A Drug delivery materials made by sol/gel technology |
| 01/23/2008 | CN101111153A Starch derivatives and other derivatives, production processes therefor, and wound healing applications therefor |
| 01/23/2008 | CN101108872A Plants natural base extractive and formulated product and use thereof |
| 01/23/2008 | CN101108869A Mangiferin salt and method of preparing the same and use thereof |
| 01/23/2008 | CN101108826A Method for normal-temperature high-pressure aconine extracting and formulated product thereof |
| 01/23/2008 | CN101108250A Mono- and disaccharide derivatives |